Literature DB >> 9605724

Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia.

W P Goldman1, J D Baty, V D Buckles, S Sahrmann, J C Morris.   

Abstract

BACKGROUND: The nature of cognitive performance in subjects with Parkinson disease (PD) without dementia is controversial, perhaps because of failure to exclude subjects with unrecognized very mild dementia.
OBJECTIVE: To compare cognitive and motor functioning in well-characterized subjects with PD without overt dementia with healthy elderly control subjects.
DESIGN: Subjects' conditions were evaluated clinically and psychometrically at entry into a longitudinal study of cognitive and motor performance in elderly subjects. Measures included a global dementia staging scale, the Washington University Clinical Dementia Rating; psychometric tests, including Logical Memory, Digit Span, Associate Learning, Information, Block Design, Digit Symbol, Trail-making A, Crossing-off, Boston Naming Test, and Word Fluency; and motor measures, including finger tapping, gait velocity, reaction time, and movement time.
SETTING: A university-based research facility.
SUBJECTS: There were 3 groups of subjects: healthy elderly control subjects (n=43), subjects with PD without dementia (n=58), and subjects with PD with questionable dementia (n=22), each evaluated at time of entry.
RESULTS: As expected, both PD groups were impaired on motor measures (gait velocity, finger tapping, and movement time) compared with the healthy elderly control group. Neither PD group showed slowing in reaction time. The subjects with PD with questionable dementia were more impaired on Logical Memory, Block Design, Digit Symbol, and Trailmaking A compared with the subjects with PD without dementia. Although free of clinically evident cognitive dysfunction (Clinical Dementia Rating score, 0), the PD group without dementia was impaired with respect to the healthy elderly control group on all measures from the psychometric assessment except Digit Span, Associate Learning, and Word Fluency.
CONCLUSIONS: The PD group without dementia showed global cognitive impairments in comparison with the healthy elderly control group, possibly because the healthy elderly control subjects represented idealized aging. Although the deficits were of small magnitude, this finding suggests that PD may predispose to subclinical cognitive impairment. Longitudinal follow-up is required to determine whether subjects with PD destined to develop overt dementia can be distinguished from those who do not.

Entities:  

Mesh:

Year:  1998        PMID: 9605724     DOI: 10.1001/archneur.55.5.674

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  22 in total

Review 1.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  D Aarsland; K Karlsen
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

Review 2.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

Review 3.  Profile of cognitive impairment in Parkinson's disease.

Authors:  G Stennis Watson; James B Leverenz
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

4.  Executive function in Parkinson's disease: contributions of the dorsal frontostriatal pathways to action and motivation.

Authors:  Susan M Ravizza; John Goudreau; Mauricio R Delgado; Sandra Ruiz
Journal:  Cogn Affect Behav Neurosci       Date:  2012-03       Impact factor: 3.282

5.  Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia.

Authors:  Blanca Ramírez-Ruiz; María José Martí; Eduardo Tolosa; David Bartrés-Faz; Chistopher Summerfield; Pilar Salgado-Pineda; Beatriz Gómez-Ansón; Carme Junqué
Journal:  J Neurol       Date:  2005-07-05       Impact factor: 4.849

6.  Cerebrospinal fluid biomarkers and cognitive performance in non-demented patients with Parkinson's disease.

Authors:  James B Leverenz; G Stennis Watson; Jane Shofer; Cyrus P Zabetian; Jing Zhang; Thomas J Montine
Journal:  Parkinsonism Relat Disord       Date:  2010-11-01       Impact factor: 4.891

Review 7.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

8.  Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.

Authors:  Anne-Marie A Wills; Jordan J Elm; Rong Ye; Kelvin L Chou; Sotirios A Parashos; Robert A Hauser; Ivan Bodis-Wollner; Vanessa K Hinson; Chadwick W Christine; Jay S Schneider
Journal:  Parkinsonism Relat Disord       Date:  2016-10-08       Impact factor: 4.891

9.  Statistically Defined Parkinson's Disease Executive and Memory Cognitive Phenotypes: Demographic, Behavioral, and Structural Neuroimaging Comparisons.

Authors:  Samuel J Crowley; Guita Banan; Manish Amin; Jared J Tanner; Loren Hizel; Peter Nguyen; Babette Brumback; Katie Rodriguez; Nikolaus McFarland; Dawn Bowers; Mingzhou Ding; Thomas A Mareci; Catherine C Price
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

10.  Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.

Authors:  V Pérez; C Marin; A Rubio; E Aguilar; M Barbanoj; J Kulisevsky
Journal:  J Neural Transm (Vienna)       Date:  2009-08-27       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.